JP2023533472A5 - - Google Patents

Info

Publication number
JP2023533472A5
JP2023533472A5 JP2022580214A JP2022580214A JP2023533472A5 JP 2023533472 A5 JP2023533472 A5 JP 2023533472A5 JP 2022580214 A JP2022580214 A JP 2022580214A JP 2022580214 A JP2022580214 A JP 2022580214A JP 2023533472 A5 JP2023533472 A5 JP 2023533472A5
Authority
JP
Japan
Application number
JP2022580214A
Other languages
Japanese (ja)
Other versions
JP2023533472A (ja
JPWO2022003421A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000451 external-priority patent/WO2022003421A2/en
Publication of JP2023533472A publication Critical patent/JP2023533472A/ja
Publication of JP2023533472A5 publication Critical patent/JP2023533472A5/ja
Publication of JPWO2022003421A5 publication Critical patent/JPWO2022003421A5/ja
Pending legal-status Critical Current

Links

JP2022580214A 2020-06-30 2021-06-30 肺非結核性真菌感染症を治療するための三重抗生物質固定用量コンビネーション製品、投与レジメン、方法及びキット Pending JP2023533472A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063046335P 2020-06-30 2020-06-30
US202063046322P 2020-06-30 2020-06-30
US63/046,335 2020-06-30
US63/046,322 2020-06-30
PCT/IB2021/000451 WO2022003421A2 (en) 2020-06-30 2021-06-30 Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

Publications (3)

Publication Number Publication Date
JP2023533472A JP2023533472A (ja) 2023-08-03
JP2023533472A5 true JP2023533472A5 (https=) 2024-07-09
JPWO2022003421A5 JPWO2022003421A5 (https=) 2024-07-09

Family

ID=79032054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022580214A Pending JP2023533472A (ja) 2020-06-30 2021-06-30 肺非結核性真菌感染症を治療するための三重抗生物質固定用量コンビネーション製品、投与レジメン、方法及びキット

Country Status (11)

Country Link
US (1) US11590154B2 (https=)
EP (1) EP4171546A4 (https=)
JP (1) JP2023533472A (https=)
KR (1) KR20230028502A (https=)
CN (1) CN115768420A (https=)
AU (1) AU2021298936A1 (https=)
BR (1) BR112022026615A2 (https=)
CA (1) CA3187031A1 (https=)
IL (1) IL299287A (https=)
MX (1) MX2023000165A (https=)
WO (1) WO2022003421A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025026423A1 (en) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, their use and manufacture for treatment of gastrointestinal conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012304A1 (es) 1997-04-01 2000-10-18 Borody Thomas J Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
PT2247291T (pt) * 2008-02-08 2019-02-01 Red Hill Biopharma Ltd Métodos e composições para tratamento de doença inflamatória do intestino
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
US20180273573A1 (en) 2015-10-01 2018-09-27 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2017194734A1 (en) 2016-05-13 2017-11-16 Technische Universität München Means and methods for treating mycobacterial diseases

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
JP2023533472A5 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)